The latest closing stock price for Intellia Therapeutics as of February 21, 2025 is 12.17.
An investor who bought $1,000 worth of Intellia Therapeutics stock at the IPO in 2016 would have $-449 today, roughly 0 times their original investment - a -6.41% compound annual growth rate over 9 years.
The all-time high Intellia Therapeutics stock closing price was 176.78 on September 03, 2021.
The Intellia Therapeutics 52-week high stock price is 34.87, which is 186.5% above the current share price.
The Intellia Therapeutics 52-week low stock price is 8.96, which is 26.4% below the current share price.
The average Intellia Therapeutics stock price for the last 52 weeks is 20.21.
An investor who bought $1,000 worth of Intellia Therapeutics stock at the IPO in 2016 would have $-449 today, roughly 0 times their original investment - a -6.41% compound annual growth rate over 9 years.
The all-time high Intellia Therapeutics stock closing price was 176.78 on September 03, 2021.
The Intellia Therapeutics 52-week high stock price is 34.87, which is 186.5% above the current share price.
The Intellia Therapeutics 52-week low stock price is 8.96, which is 26.4% below the current share price.
The average Intellia Therapeutics stock price for the last 52 weeks is 20.21.